3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
- 3 May 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (12) , 2388-2409
- https://doi.org/10.1021/jm010531d
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Conformational Restriction of Flexible Ligands Guided by the Transferred NOE Experiment: Potent Macrocyclic Inhibitors of FarnesyltransferaseJournal of the American Chemical Society, 2001
- Inhibitors of protein prenylation 1999Expert Opinion on Therapeutic Patents, 1999
- Design and in Vivo Analysis of Potent Non-Thiol Inhibitors of Farnesyl Protein TransferaseJournal of Medicinal Chemistry, 1999
- Chemoselective aryl alkyl ether cleavage by thiophenolate anion through its in situ generation in catalytic amountTetrahedron Letters, 1997
- [21] Data collection strategyPublished by Elsevier ,1997
- P-Glycoproteins and Multidrug ResistanceAnnual Review of Pharmacology and Toxicology, 1996
- A practical process for the preparation of tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole-borane. A highly enantioselective stoichiometric and catalytic reducing agentThe Journal of Organic Chemistry, 1993
- π-π interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteinsJournal of Molecular Biology, 1991
- Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanicsJournal of Computational Chemistry, 1990
- p21ras is modified by a farnesyl isoprenoid.Proceedings of the National Academy of Sciences, 1989